title: Examination of oral sensitization with ovalbumin in Brown Norway rats and three strains of mice.
abstract: We studied the conditions needed to sensitize animals to the oral feeding of food allergens, without induction of tolerance, in order to investigate the allergenicity of orally ingested food proteins. Brown Norway (BN) rats were sensitized by daily OVA (ovalbumin)-gavage or by drinking OVA containing water ad libitum and the ASA (active systemic anaphylaxis) response, as the immediate hypersensitivity response to antigen stimulation after oral sensitization, was examined. The oral administration of OVA by gavage produced a higher OVA-specific IgE response and an increase in serum histamine after antigen challenge, as compared to those produced by drinking water. Next, we examined the effect of murine age, the oral feeding technique and the oral feeding dose on sensitization using BALB/c, B10A and ASK mice. Twenty-week-old mice showed the strongest OVA-specific IgE and IgG1 responses and ASA-associated serum histamine contents increased with gavage in the three different age groups of BALB/c mice. Administering 0.1 mg of OVA by gavage daily for 9 weeks appeared to induce a higher response than administering 1 mg of OVA, in terms of OVA-specific IgE and IgG1 antibody responses and ASA responses. Among the three strains of mice, B10A mice exhibited the highest response in terms of OVA-specific IgE and IgG1 antibody and ASA responses. These findings suggested BN rats and B10A mice were suitable models for oral sensitization with antigen protein and that oral sensitization in mice requires low dose, intermittent antigen intakes.
authors.affiliation: Division of Foods, National Institute of Health Sciences, 1-18-1, Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan. akiyama@nihs.go.jp
authors.forename: H
authors.initials: H
authors.lastname: Akiyama
authors.forename: R
authors.initials: R
authors.lastname: Teshima
authors.forename: J I
authors.initials: JI
authors.lastname: Sakushima
authors.forename: H
authors.initials: H
authors.lastname: Okunuki
authors.forename: Y
authors.initials: Y
authors.lastname: Goda
authors.forename: J I
authors.initials: JI
authors.lastname: Sawada
authors.forename: M
authors.initials: M
authors.lastname: Toyoda
mesh_terms: D000284:Administration, Oral; D000367:Age Factors; D000485:Allergens / Q000008:administration & dosage / Q000276:immunology*; D000707:Anaphylaxis / Q000276:immunology; D000818:Animals; D004195:Disease Models, Animal; D005260:Female; D006632:Histamine / Q000097:blood; D006967:Hypersensitivity / Q000097:blood / Q000209:etiology / Q000276:immunology*; D007073:Immunoglobulin E / Q000097:blood; D007074:Immunoglobulin G / Q000097:blood; D051379:Mice; D008807:Mice, Inbred BALB C; D010047:Ovalbumin / Q000008:administration & dosage / Q000276:immunology*; D051381:Rats; D011914:Rats, Inbred BN; D013045:Species Specificity; D013997:Time Factors
chemical_list: D000485:Allergens; D007074:Immunoglobulin G; D007073:Immunoglobulin E; D006632:Histamine; D010047:Ovalbumin